- Home
- BTGO vs CTMX Comparison
BTGO vs CTMX Comparison
Compare BTGO & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BTGO | CTMX |
|---|---|---|
| Founded | 2013 | 2008 |
| Country | United States | United States |
| Employees | 603 | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 961.8M | 977.1M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | BTGO | CTMX |
|---|---|---|
| Price | $11.92 | $3.87 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 10 |
| Target Price | ★ $14.83 | $12.10 |
| AVG Volume (30 Days) | 501.1K | ★ 3.4M |
| Earning Date | 05-13-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $76,201,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $34.41 | $7.61 |
| P/E Ratio | ★ $10.81 | $22.58 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.25 | $1.72 |
| 52 Week High | $15.30 | $8.21 |
Technical Indicators
Market Signals| Indicator | BTGO | CTMX |
|---|---|---|
| Relative Strength Index (RSI) | 57.19 | 35.00 |
| Support Level | $9.62 | $3.39 |
| Resistance Level | $12.11 | $3.91 |
| Average True Range (ATR) | 0.77 | 0.23 |
| MACD | 0.17 | -0.04 |
| Stochastic Oscillator | 67.11 | 3.53 |
Price Performance
Historical ComparisonAbout BTGO BitGo Holdings Inc. Class A Common Stock
BitGo Holdings Inc provides various offerings to its clients including multi-signature blockchain wallet solutions allowing for secure storage, trade settlement, staking solutions, and lending of digital assets. The Company also provides professional services to develop smart contracts. Its clients range from crypto-native companies that use its self-custody wallet technology to traditional financial services firms that leverage its licensed custody, staking and trading capabilities within their own products and services.
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.